Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer

PaperCitations, authors & open-access status

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 424 citations, 2019 year and closed oa status.

424
Citations
2019
Year
closed
OA Status

Related on ScholarIQ

Vanita Noronha
Author
Vijay Patil
Author
Abhishek Mahajan
Author
Atanu Bhattacharjee
Author
Kumar Prabhash
Author
Journal of Clinical Oncology
Journal
470M+ articles · free account